Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Effects of Wolbitang on Obese Rats Induced by High Cholesterol Diet

고(高)콜레스테롤 식이(食餌)로 유도된 비만 흰쥐에 대한 월비탕(越婢湯)의 효과

  • Park, Woong-Duck (Department of Herbology, College of Oriental Medicine, Kyungwon University) ;
  • Lee, Young-Jong (Department of Herbology, College of Oriental Medicine, Kyungwon University)
  • 박웅덕 (경원대학교 한의과대학 본초학교실) ;
  • 이영종 (경원대학교 한의과대학 본초학교실)
  • Published : 2005.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Four kinds of decoctions (Wolbi-tang, Wolbigachul-tang, Wolbigabanha-tang and Wolbi-tang with Psyllium Husk diet)was prescribed to examined the therapeutic effects on hyperlipidemia. Four decoctions prepared from the prescriptions were respectively administrated to the corpulent rats induced by a high cholesterol diet. Wolbi-tang mollified the increasing rate of the body weight, and decreased the amount of food eaten. It slightly increased the concentrations of blood Tc, blood TG, blood FFA, and lipids in feces, and decreased the contents of blood HDL-c. Wolbigachul-tang mollified the increasing rate of the body weight, and decreased the amount of food eaten. It decreased the amount of FFA and HDL-c lipids in the blood. Wolbigabanha-tang mollified the increasing rate of the body weight, and decreased the amount of food eaten. Also, it decreased the concentrations of blood glucose. However, it increased the content of blood HDL-c. Wolbi-tang with Psyllium Husk diet mollified the increasing rate of body weight, and decreased the amount of food eaten. Also, it slightly decreased the concentrations of blood TG and blood FFA, but increased the concentrations of blood Tc. Considering the above results, four kinds of decoctions(Wolbi-tang, Wolbigachul-tang, Wolbigabanha-tang and Wolbi-tang with Psyllium Husk diet) could be applied for the treatment of obesity, and Wolbigabanha-tang would be the most recommendable among them.

Keywords

References

  1. 金榮卨. 肥滿症의 槪念과 診斷, 大韓醫學協會誌 37(2):1008-1014, 1994.
  2. 최영길. 내분비학. 서울:의학출판사. 735-742, 1994.
  3. 林瑩鎬, 李鍾秀, 金性洙, 申鉉大. 五苓散이 肥滿誘導 白鼠의 肝과 副睾丸周圍의 脂肪組織, 血淸脂質 및 尿中 Hormone 의 變化에 關한 硏究. 한방재활의학회지 8(2):16-41, 1998
  4. 洪元植. 精校黃帝內經. 서울:동양의학연구원 출판부. pp.107-111, 176-179, 181-191, 255-279, 1985.
  5. 朱震亨. 丹溪心法附餘(上). 서울: 대성출판사. p66, 67, 70, 156, 1992
  6. 中醫硏究院主編. 中醫症狀鑑別診斷學. 北京:人民衛生出版社. p.43, 1987.
  7. 楊金榮 等. 耳穴点壓 減肥500例. 陜西中醫. 3:23-24, 1983.
  8. 呂明莊. 耳穴按壓法. 減肥1000例. 臨床療效報導. 貴州醫藥. 5: 67, 1967.
  9. 程銘 等. 靜坐呼吸法 減肥治療的觀察. 江蘇中醫. 1: 18-20, 1991.
  10. 장병수. 반하(半夏)가 비만유도 흰쥐의 체중, 지방조직, 혈액 및 유전자 변화에 미치는 영향. 경희대학교 박사학위논문. 1999.
  11. 이승훈. 동아(Benicasa hispida)의 식이가 비만을 유도한 흰쥐의 혈청성분에 미치는 영향. 명지대학교 석사학위논문. 1998.
  12. 고광재. 산사추출액이 백서의 비만모형에 미치는 영향. 원광대학교 석사학위논문. 1998.
  13. 신동준. 태음조위탕과 마황이 비만 백서의 leptin에 미치는 영향. 상지대학교 석사학위논문. 1999.
  14. 金南洙, 宋勇善. 拘杞子抽出液이 白鼠의 肥滿模型에 미치는 影響. 한방재활의학학회지 7(2):65-83, 1997.
  15. 송용선, 이명종, 정석희, 김성수, 이종수, 신현대. 방기황기탕 및 구기자가 비만백서의 체중에 미치는 영향. 동의물리요법학회지 1(1):25-43, 1991.
  16. 배정환, 이종수, 김성수, 신현대. 大黃이 肥滿誘導 白鼠의 體重과 副睾丸脂肪組織 變化에 미치는 影響에 대한 硏究. 한방재활의학회지 8(2):62-76, 1998.
  17. 吳明吉, 宋勇善. 大黃 抽出液이 白鼠의 肥滿模型에 미치는 影響. 한방재활의학회지 7(2):46-64, 1997
  18. 송윤경. 동규자 추출액이 백서의 비만증과 비만유도세포 3T3-L1의 분회에 미치는 영향. 원광대학교 석사학위논문 1996.
  19. 김수익, 송용선. 방기황기탕 전탕액이 백서의 실험적 비만증과 전지방세포인 3T3-L1의 지방세포분화에 미치는 영향. 한방재활의학회지 7(1):120-135, 1997.
  20. Vansal, S.S., Dennis, R.F. Direct effects of ephedrine isomer on human $\beta$-adrenergic receptor subtypes. Biochem Pharm 58, 807-810, 1999.
  21. Gurley, B. Extract versus herb: effect of formulation on the absorption rate of botanical ephedrine from dietary supplements containing Ephedra. Ther Drug Monit. 22(4):497, 2000.
  22. Gurley, B.J., Wang, P., Gardner, S.F. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography. J Pharm Sci 87(12):1547-1553, 1998.
  23. Gurley, B.J., Gardner, S.F., White, L.M., Wang, P.L. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (Ma huang). Ther Drug Monit 20(4):439-445, 1998.
  24. White, L.M., Gardner, S.F., Gurley, B.J., Marx, M.A., Wang. P.L., Estes, M. Pharmacokinetics and cardiovascular effects of Ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol 37(2):116-122, 1997.
  25. 楊何輝 主編. 金匱要略 註釋. 臺北: 國立編譯館 出版. p.71,98,99,184,1.,92,193, 1986.
  26. 宗全和 主編. 中醫方劑通釋 卷1. 石家庄: 河北科學技術出版社. pp.95-97,245-247, 1995.
  27. Mertens, I.L., Van Gaal, L.F. Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res. 8(3):270-278, 2000.
  28. Kahn, B.B., Flier, J.S. Obesity and insulin resistance. J Clin Invest 106(4):473-481, 2000.
  29. Abate, N. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14(3):154-174, 2000.
  30. Seinige, V.L., Sataloff, D.M., Lieber, C.P., DeliaCroce, J.M., Sorouri, E.S. Gallbladder Disease in the Morbidly Obese Patient. Obes Surg 1(1):51-56, 1991.
  31. 허수영. 청폐사간탕이 백서의 실험적 비만에 미치는 영향. 경산대학교 석사학위논문. 1999
  32. 박정환. 백개자 약침이 비만 유도 흰쥐의 체중 및 지질대사에 미치는 영향. 경희대학교 석사학위논문. 1999.
  33. 최용태, 이윤호, 강성길. 비만증의 이침요법에 대한 임상적 고찰. 황제의학. 1(2):26-29, 1976.
  34. Carek, P.J., Dickerson, L.M. Current concepts in the pharmacological management of obesity. Drugs 57(6):883-904, 1999. https://doi.org/10.2165/00003495-199957060-00005
  35. Cheymol, G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 39(3):215-231, 2000.
  36. Tulp, O.L., Abdollahi, A, Stevens, C. Schnitzer-Polokoff, R. The effects of the intestinal glucosidase inhibitor acarbose on cholestcrogenesis in corpulent rats. Comp Biochem Physiol A 100(3):763-768, 1991.
  37. Teter, C.J., Early, J.J., Gibbs, C.M. Treatment of affective disorder and obesity with topiramate. Ann Pharmacother 34(11):1262-1265, 2000.
  38. Chikamori, T., Sugimoto, K., Hamada, T., Kitaoka, H., Furuno, T., Seo, H., Doi, Y. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. J Cardiol 35(2):95-101, 2000.
  39. Kasim, S.E., Leboeuf, R.C. Khilnani, S., Tallapaka, L., Dayananda, D., Jen, K.L. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J Lipid Res 33(1):1-7, 1992.
  40. Schteingarl, D.E. Effectiveness of phenylpropanolamine in the management of moderate obesity. Int JObes Relat Metab Disord 16(7):487-493, 1992.
  41. Rieger, G. Paranoid hallucinatory psychosis following medication with anorectics containing D-nor-pseudoephedrin. Case report Nervenarzt 52(7):423-425, 1981.
  42. Poston, W.S. 2nd, Foreyt. J.P. Scientific and legal issues in fenfluraminej dexfenfluramine litigation. Tex Med 96(2):48-56, 2000.
  43. McCann, U.D., Seiden, L.S., Rubin, L.J., Ricaurte, G.A. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. JAMA 278(8):666-672, 1997.
  44. Seewi, G., Cnauck, G., Stute, R., Chantelau, E. Effects on parameters of glucose homeostasis in healthy humans from ingestion of leguminous versus maize starches. Eur J Nutr 38(4):183-189, 1999.
  45. Daly, M.E., Vale, C, Walker, M., Littlefield, A., Alberti, K.G., Mathers, J.C Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr 67(6):1186-1196, 1998.
  46. Kritchevsky, D., Tepper, SA, Klurfeld, D.M. Influence of psyllium preparations on plasma and liver lipids of cholesterol-fed rats. Artery 21(6):303-311, 1995.
  47. Rodriguez-Moran, M., Guerrero-Romero, F., Lazcano-Burciaga, G. Lipid-andglucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications 12(5):273-278, 1998.
  48. Turnbull, W.H., Thomas, H.G. The effect of a plantago ovata seed containing preparation on appetite variables, nutrient and energy intake. Int J Obes Relat Metab Disord 19(5):338-342, 1995.
  49. Gelissen, I.C, Brodie, B., Eastwood, M.A. Effect of Plantago ovata husk and seeds on sterol metabolism. Am J Gin Nutr 59(2):395-400, 1994.